Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 231 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CIPROFLOXACIN INTRAVENOUS INFUSION, BP | 2MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19335 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2017-10-17 | 2017-12-15 | 26163 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2017-11-28 | 2018-01-29 | 31019 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-02-01 | 2018-08-20 | 37986 |
APO-ALPRAZ TS | 2MG | TABLET | Resolved | 2018-07-04 | 2020-09-28 | 54168 |
APO-GLIMEPIRIDE | 2MG | TABLET | Resolved | 2018-07-11 | 2019-09-21 | 55281 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2018-08-09 | 2018-11-19 | 57802 |
APO-TERAZOSIN | 2MG | TABLET | Resolved | 2018-10-19 | 2018-12-27 | 65008 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2018-10-25 | 2018-11-26 | 65588 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-12-05 | 2019-12-16 | 100255 |
APO-HYDROMORPHONE | 2MG | TABLET | Resolved | 2020-04-07 | 2020-05-22 | 111224 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-05-08 | 2020-07-13 | 114282 |
APO-WARFARIN | 2MG | TABLET | Resolved | 2020-05-13 | 2020-07-28 | 114975 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-08 | 2020-09-04 | 119765 |
APO-DOXAZOSIN | 2MG | TABLET | Resolved | 2020-07-23 | 2020-11-16 | 120982 |
APO-PERINDOPRIL | 2MG | TABLET | Resolved | 2020-07-23 | 2020-09-04 | 120985 |
APO-LORAZEPAM | 2MG | TABLET | Resolved | 2020-08-12 | 2020-10-05 | 122071 |
APO-PRAZO TAB 2MG | 2MG | TABLET | Resolved | 2020-09-02 | 2020-10-16 | 123574 |
APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2020-09-22 | 2020-11-27 | 124795 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126254 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
APO-CARVEDILOL | 3.125MG | TABLET | To be discontinued | 2024-01-26 | 2024-01-26 | 217496 |
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG 300MG | TABLET | Discontinued | 2022-12-12 | 2022-12-12 | 177953 |
APO-DILTIAZ TZ | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1075 |
APO-NIZATIDINE | 300MG | CAPSULE | Discontinued | 2017-03-13 | 2017-03-13 | 1135 |
APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
APO-CLINDAMYCIN | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2019-07-13 | 60399 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-QUININE | 300MG | CAPSULE | Discontinued | 2018-09-08 | 2021-05-10 | 60714 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |